Sino Biopharmaceutical reported CNY1.33B in Operating Profit for its fiscal semester ending in December of 2024.


Operating Profit Change Date
Alaunos Therapeutics USD -755000 395K Dec/2024
Avita Medical AUD -9957000 5.64M Dec/2024
Cspc Pharmaceutical CNY 1.79B 940.51M Mar/2025
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Jiangsu Hengrui CNY 2.8B 716.13M Jun/2025
Moderna USD -907000000 143M Jun/2025
Organon & Co USD 326M 225M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Sino Biopharmaceutical CNY 1.33B 2.53B Dec/2024
Tectonic Therapeutic USD -22330000 8.34M Jun/2025
Viatris USD 185.4M 3.21B Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025